Candriam S.C.A. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$648,665
-71.0%
29,401
-45.2%
0.00%
-78.9%
Q1 2021$2,235,000
-4.0%
53,6330.0%0.02%
+5.6%
Q4 2020$2,327,000
-32.0%
53,633
-32.7%
0.02%
-43.8%
Q3 2020$3,420,000
-8.2%
79,7200.0%0.03%
-17.9%
Q2 2020$3,726,00079,7200.04%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders